DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

被引：0
|
作者：
Capecchi, M. [1 ]
Corradini, P. [1 ]
Montefusco, V. [1 ]
机构：
[1] Ist Nazl Tumori, Ematol Trapianto Midollo Osseo, Milan, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1983
引用
收藏
页码：795 / 796
页数：2
相关论文
共 50 条
  • [1] Diarrhea Incidence in Multiple Myeloma Patients Treated With Lenalidomide and Pomalidomide
    Montefusco, Vittorio
    Capecchi, Marco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E46 - E46
  • [2] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [3] Successful retreatment with lenalidomide for relapsed and refractory multiple myeloma previously treated with bortezomib, lenalidomide and pomalidomide
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (06) : 914 - 917
  • [4] High incidence of diarrhea in patients on long term therapy with lenalidomide and dexamethasone for multiple myeloma
    Simpson, L.
    Rajkumar, S. V.
    Dispenzieri, A.
    Lacy, M. Q.
    Hayman, S.
    Roy, V.
    Stewart, K.
    Gertz, M. A.
    Greipp, P. R.
    Kumar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Hultcrantz, Malin
    Hassoun, Hani
    Korde, Neha
    MacLachlan, Kylee
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn Rose
    Chung, David J.
    Lahoud, Oscar B.
    Landau, Heather J.
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Pianko, Matthew J.
    Burge, Miranda
    Barnett, Kelly
    Salcedo, Meghan
    Caple, Julia
    Tran, Linh
    Blaslov, Jenna
    Shekarkhand, Tala
    Hamid, Selena
    Nemirovsky, David
    Derkach, Andriy
    Arisa, Oluwatobi
    Peer, Cody J.
    Figg, William D.
    Usmani, Saad Z.
    Landgren, Ola
    Lesokhin, Alexander M.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [6] Evaluating the use of appropriate anticoagulation with lenalidomide and pomalidomide in patients with multiple myeloma
    Anderson, Sarah M.
    Beck, Bradley
    Sterud, Susan
    Lockhorst, Robin
    Ngorsuraches, Surachat
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 806 - 812
  • [7] NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
    Burke, Martyn J.
    George, Elisabeth
    Adler, Amanda I.
    LANCET ONCOLOGY, 2015, 16 (05): : 492 - 493
  • [8] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
    Paludo, Jonas
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Halvorson, Alese E.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Stewart, A. Keith
    Reeder, Craig B.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    BLOOD, 2017, 130 (10) : 1198 - 1204
  • [9] THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE
    Palmaro, A.
    Despas, F.
    Lapeyre-Mestre, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E65 - E65
  • [10] POMALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA
    Gras, J.
    DRUGS OF TODAY, 2013, 49 (09) : 555 - 562
12345